๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bone Marker Alterations in Patients with Type 1 Gaucher Disease

โœ Scribed by G. Ciana; C. Martini; A. Leopaldi; G. Tamaro; F. Katouzian; L. Ronfani; B. Bembi


Publisher
Springer
Year
2003
Tongue
English
Weight
88 KB
Volume
72
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Bone density in type 1 gaucher disease
โœ Gregory M. Pastores; Sylvan Wallenstein; Robert J. Desnick; Marjorie M. Luckey ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 658 KB

Skeletal involvement is a major source of complications in patients with Type 1 Gaucher disease. To investigate the bone density and potential usefulness of bone densitometry in Gaucher disease, dual-energy X-ray absorptiometry was used to measure the density of the lumbar spine, femoral neck, troch

Glucocerebrosidase gene mutations in pat
โœ Deborah L. Stone; Nahid Tayebi; Eduard Orvisky; Barbara Stubblefield; Victor Mad ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB ๐Ÿ‘ 1 views

## Communicated by Mark Paalman Gaucher disease, the most common lysosomal storage disorder, results from the inherited deficiency of the enzyme glucocerebrosidase. Three clinical types are recognized: type 1, nonneuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic. Type 2